课题基金 / 基金详情

Molecular Medicine of Leptin Regulation of Energy Metabolism and Its Medical Application

Molecular Medicine of Leptin Regulation of Energy Metabolism and Its Medical Application
瘦素调节能量代谢的分子医学及其医学应用
批准号:
15390294
负责人:
OGAWA Yoshihiro
金额:
$9.34万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

OGAWA Yoshihiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Leptin is an important adipocytokine that acts directly on the hypothalamus, thereby regulating food intake and energy expenditure. Because leptin receptor is expressed not only in the hypothalamus but in a variety of peripheral tissues and leptin is capable of activating the JAK/STAT signaling pathway, suggesting that leptin works as a proinflammatory cytokine in peripheral target tissues.1)Leptin as an antidiabetic agent in insulin-deficient diabetes : We showed that after streptozotocin injection, both transgenic skinny mice overexpressing leptin and their non-transgenic littermates developed marked hyperglycemia as a result of severe hypoinsulinemia (termed diabetic TGM and diabetic WT, respectively). Diabetic TGM became normoglycemic, when treated with insulin at such doses that did not improve hyperglycemia in diabetic WT. This study suggests that leptin can be used as an adjunct of insulin therapy in insulin-deficient diabetes, thereby providing an insight into the therapeutic implication of leptin as an anti-diabetic agent.2)Pathonhvsioloizic role of leptin in ischemia-induced retinal neovascularization : Using the mouse retinopathy of prematurity model, we showed that leptin stimulates ischemia-induced retinal neovascularization possibly through the upregulation of endothelial VEGF. These observations suggest that leptin antagonism may offer a novel therapeutic strategy to prevent or treat diabetic retinopathy.3)Diagnostic role of leptin in as a biomarker of atherosclerosis : Given that leptin and adiponectin are important mediators linking adiposity and atherosclerosis in the adipovascular axis, we demonstrated that leptin/adiponectin ratio is strongly correlated with pulse-wave velocity, a direct measure of arterial stiffness. We, therefore, postulate that the ratio may serve as a potential atherogenic index in obese type 2 diabetic patients.
期刊论文(42)
专著(0)
科研奖励(0)
会议论文
DOI: 10.2337/diabetes.53.9.2443
发表时间: 2004-09-01
期刊: DIABETES
影响因子: 7.7
作者: [Suganami, E, Takagi, H, Yoshimura, N]
通讯作者: Yoshimura, N
F.Miyanaga et al.: "Leptin as an adjunct of insulin therapy in insulin-dependent diabetes."Diabetologia. 46. 1329-1337 (2003)
F.Miyanaga 等人:“瘦素作为胰岛素依赖型糖尿病中胰岛素治疗的辅助手段。”Diabetologia。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K.Yamahara et al.: "Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration."Proc.Natl.Acad.Sci.USA. 100. 3404-3409 (2003)
K.Yamahara 等人:“利钠肽/cGMP/cGMP 依赖性蛋白激酶途径在血管再生中的意义和治疗潜力。”Proc.Natl.Acad.Sci.USA。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Nakagawa et al.: "Antiobesity and antidiabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance"Int. J. Obes.. 27. 557-565 (2003)
T.Nakakawa 等人:“脑源性神经营养因子在瘦素抵抗啮齿动物模型中的抗肥胖和抗糖尿病作用”Int。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
10
    Molecular mechanism of tissue fibrosis and develpment of revolutionary anti-fibrotic therapy
    • 批准号:
      25670439
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      OGAWA Yoshihiro
    • 依托单位:
    Concept of Physiologic Inflammation and Its Functional Significance
    • 批准号:
      24659450
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      OGAWA Yoshihiro
    • 依托单位:
    Identification of target genes for DNA methylation in skeletal muscle and its medical application
    • 批准号:
      23659468
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2011
    • 负责人:
      OGAWA Yoshihiro
    • 依托单位:
    Molecular Mechanism of Metabolic Memory via a DNA Methylation and Its Medical Application
    • 批准号:
      23390240
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.4万
    • 财政年份:
      2011
    • 负责人:
      OGAWA Yoshihiro
    • 依托单位:
    国内基金
    海外基金
    同源异形盒基因HvVvl介导20E信号通路和insulin信号通路调控茄二十八星瓢虫变态发育的分子机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      潘慧鹏
    • 依托单位:
    基于稳态吸收和DPP-IV/GLP-1/Insulin通路解析牡蛎肽协同花色苷的降血糖增效机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      陈忠琴
    • 依托单位:
    Dif/FoxO激活miRNA调节Toll与insulin信号交互促进果蝇免疫代谢平衡的机制研究
    • 批准号:
      32370516
    • 项目类别:
      面上项目
    • 资助金额:
      51万元
    • 批准年份:
      2023
    • 负责人:
      马飞
    • 依托单位:
    基于多组学解析光环境促Insulin基因甲基化抑制PI3K/ACTBL2延缓近视发展的分子机制
    • 批准号:
      82301246
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      黄煜
    • 依托单位: